통풍 치료제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 유형별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Gout Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Distribution Channel, By Region, By Competition 2020-2030F
상품코드:1881712
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 통풍 치료제 시장은 2024년에 21억 6,000만 달러로 평가되었으며, 2030년까지 CAGR 8.8%로 성장하여 35억 8,000만 달러에 달할 것으로 예측됩니다.
통풍 치료제는 관절 내에 요산나트륨 결정이 침착되는 염증성 관절 질환인 통풍의 급성기 및 만성기 증상을 관리하기 위해 특별히 고안된 의약품입니다. 이러한 치료법은 주로 혈청 요산 수치를 낮추고 염증 반응을 완화하는 것을 목표로 합니다. 시장 확대의 주요 요인은 고령화 및 비만, 고혈압 등 관련 대사성 합병증 증가로 인해 악화되는 전 세계 통풍 환자의 증가입니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
21억 6,000만 달러
시장 규모 : 2030년
35억 8,000만 달러
CAGR : 2025-2030년
8.8%
가장 빠르게 성장하는 부문
요산저하제
최대 시장
북미
주요 시장 촉진요인
통풍 치료제 시장 확대의 주요 촉진요인은 전 세계적으로 증가하는 통풍 유병률입니다. 고령화, 생활습관 변화 등 다양한 요인에 의해 유발되는 이 염증성 질환은 전 세계 인구의 상당수에게 지속적으로 영향을 미치고 있습니다.
주요 시장 과제
세계 통풍 치료제 시장의 성장을 저해하는 주요 요인은 첨단 치료 옵션에 따른 높은 비용과 제한적인 상환 정책입니다. 이러한 경제적 장벽은 특히 개발도상국에서 환자들이 혁신적이고 효과적인 치료를 받을 수 있는 기회를 직접적으로 제한하고 있습니다.
주요 시장 동향
세계 통풍 치료제 시장은 현재 보다 전문적이고 진보된 치료법으로의 전환기를 맞이하고 있습니다. 여기에는 기존 치료법에 비해 보다 정밀한 작용 기전을 제공하는 표적 생물학적 치료법에 대한 관심이 높아지고 있는 현저한 추세가 포함됩니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 통풍 치료제 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
약물 유형별(NSAIDs, 콜히친, 요산저하제, 생물학적 제제)
유통 채널별(병원 약국, 소매 약국, 온라인 약국)
지역별
기업별(2024)
시장 맵
제6장 북미의 통풍 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 통풍 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 통풍 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 통풍 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 통풍 치료제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 통풍 치료제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Abbott Laboratories Inc
Medtronic Plc
Boston Scientific Corp
Becton, Dickinson and Company
Novartis AG
GlaxoSmithKline plc
Allergen, Inc.
W. L. Gore & Associates, Inc.
Stryker Corporation
Terumo Corporation
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Gout Therapeutics Market, valued at USD 2.16 Billion in 2024, is projected to experience a CAGR of 8.8% to reach USD 3.58 Billion by 2030. Gout therapeutics comprise pharmaceutical interventions explicitly designed to manage the acute and chronic manifestations of gout, an inflammatory arthritic condition characterized by the deposition of monosodium urate crystals within joints. These treatments primarily aim to reduce serum uric acid levels and mitigate inflammatory responses. The market's expansion is significantly driven by the escalating global prevalence of gout, exacerbated by an aging population and the increasing incidence of associated metabolic comorbidities, such as obesity and hypertension.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.16 Billion
Market Size 2030
USD 3.58 Billion
CAGR 2025-2030
8.8%
Fastest Growing Segment
Urate-lowering Drugs
Largest Market
North America
Key Market Drivers
The escalating global prevalence of gout represents a primary catalyst for market expansion in gout therapeutics. This inflammatory condition, driven by various factors including an aging population and lifestyle changes, continues to affect a substantial portion of the worldwide populace. According to a study published in *The Lancet Rheumatology*, in July 2024, 55.8 million people globally had gout in 2020, with projections indicating a significant increase over the coming decades. This rising patient demographic directly translates into an increased demand for effective diagnostic tools and a broad spectrum of treatment modalities, ranging from acute flare management to long-term urate-lowering therapies, placing considerable pressure on healthcare systems to provide comprehensive care.
Key Market Challenges
A significant challenging factor impeding the growth of the Global Gout Therapeutics Market is the high cost associated with advanced therapeutic options, coupled with restrictive reimbursement policies. These financial barriers directly limit patient access to innovative and effective treatments, especially in regions with developing economies. When patients cannot afford or access necessary medications due to prohibitive pricing or insufficient insurance coverage, market penetration for these therapies is severely curtailed.
Key Market Trends
The Global Gout Therapeutics Market is currently experiencing a significant shift towards more specialized and advanced treatment modalities. This includes a notable trend in the increasing focus on targeted biologic therapies, which offer more precise mechanisms of action compared to conventional treatments. These therapies aim to address specific pathways involved in gout pathogenesis, particularly for patients who do not respond adequately to traditional urate-lowering agents. According to MedCity News, on July 19, 2024, GRO Biosciences raised $60 million in Series B financing to advance its engineered protein technology for gout, aiming to overcome immune response limitations of existing biologic treatments.
Key Market Players
Abbott Laboratories Inc
Medtronic Plc
Boston Scientific Corp
Becton, Dickinson and Company
Novartis AG
GlaxoSmithKline plc
Allergen, Inc.
W. L. Gore & Associates, Inc.
Stryker Corporation
Terumo Corporation
Report Scope:
In this report, the Global Gout Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Gout Therapeutics Market, By Drug Type:
NSAIDs
Colchicine
Urate-lowering Drugs
Biologics
Gout Therapeutics Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Gout Therapeutics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Gout Therapeutics Market.
Available Customizations:
Global Gout Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gout Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type (NSAIDs, Colchicine, Urate-lowering Drugs, Biologics)
5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Gout Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Distribution Channel
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Gout Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Distribution Channel
6.3.2. Canada Gout Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Distribution Channel
6.3.3. Mexico Gout Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Distribution Channel
7. Europe Gout Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Distribution Channel
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gout Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Distribution Channel
7.3.2. France Gout Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Distribution Channel
7.3.3. United Kingdom Gout Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Distribution Channel
7.3.4. Italy Gout Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Distribution Channel
7.3.5. Spain Gout Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Distribution Channel
8. Asia Pacific Gout Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Distribution Channel
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gout Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Distribution Channel
8.3.2. India Gout Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Distribution Channel
8.3.3. Japan Gout Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Distribution Channel
8.3.4. South Korea Gout Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Distribution Channel
8.3.5. Australia Gout Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Distribution Channel
9. Middle East & Africa Gout Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Distribution Channel
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gout Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Distribution Channel
9.3.2. UAE Gout Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Distribution Channel
9.3.3. South Africa Gout Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Distribution Channel
10. South America Gout Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Distribution Channel
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gout Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Distribution Channel
10.3.2. Colombia Gout Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Distribution Channel
10.3.3. Argentina Gout Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Gout Therapeutics Market: SWOT Analysis
